企業プロフィール
Navidea 株価・ニュース・カタリスト
- ティッカー:
- NAVB
- 取引所:
- AMEX
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for NAVB.
企業概要
事業概要
Navidea Biopharmaceuticals is a biotechnology company that has historically focused on diagnostic and targeted molecular imaging approaches. Its story reflects the difficulty of sustaining a narrow clinical and commercial platform over time.
所在地とセクター分類
Navidea is headquartered in the United States and listed on NYSE American. It sits in small-cap biotech and medical imaging-adjacent therapeutics.
ビジネスモデルの特徴
The company depends on corporate restructuring, financing, and the ability to preserve value in a very narrow asset set. Investors historically watched regulatory developments and strategic shifts.
バイオ業界での位置付け
Navidea occupies a legacy small-cap biotech niche. The stock has long been driven more by capital structure and survival than by broad commercial scale.
今後のカタリスト
- Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on what remains.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。